Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use YUPELRI® safely and effectively. See full prescribing information for YUPELRI. YUPELRI (revefenacin) inhalation solution, for oral inhalation Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
YUPELRI is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
- generic_name
- revefenacin
- product_names
- revefenacin
- ndc
- 49502-806, 49502-806-32, 49502-806-93, 49502-806-77, 49502-806-33, 49502-806-87
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en